Two Sigma Securities’s United Therapeutics UTHR Stock Holding History

Two Sigma Securities’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,900	Closed	-$1.4M	–	3242
2024 Q3	$1.4M	Sell	3,900 -18,700	-83%	-$6.32M	0.02%	716
2024 Q2	$7.2M	Buy	22,600 +14,900	+194%	+$3.94M	0.09%	270
2024 Q1	$1.77M	Buy	+7,700	New	+$1.74M	0.02%	818
2023 Q4	–	Sell	-1,000	Closed	-$226K	–	3621
2023 Q3	$226K	Buy	+1,000	New	+$230K	﹤0.01%	2212
2023 Q2	–	Sell	-900	Closed	-$202K	–	3376
2023 Q1	$202K	Sell	900 -3,600	-80%	-$887K	﹤0.01%	2092
2022 Q4	$1.25M	Buy	+4,500	New	+$1.14M	0.04%	594
2020 Q4	–	Sell	-2,200	Closed	-$222K	–	1963
2020 Q3	$222K	Buy	+2,200	New	+$241K	﹤0.01%	1053
2019 Q4	–	Sell	-4,200	Closed	-$335K	–	2668
2019 Q3	$335K	Buy	+4,200	New	+$338K	﹤0.01%	1459
2019 Q2	–	Sell	-2,900	Closed	-$340K	–	2439
2019 Q1	$340K	Buy	+2,900	New	+$338K	﹤0.01%	1106

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Two Sigma Securities's UTHR Position: Q2 2026 in Review

Two Sigma Securities increased its United Therapeutics (UTHR) stake by 435% in Q2 2026, buying an estimated $1.25M and bringing the position to 2,726 shares worth $1.48M. The position accounts for 0.13% of the portfolio, ranked #172.

Two Sigma Securities first reported a position in UTHR in Q3 2015 and has held it in 16 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Two Sigma Securities held 2,726 shares of United Therapeutics worth $1.48M as of Q2 2026.
Two Sigma Securities bought 2,216 United Therapeutics shares in Q2 2026, an estimated $1.25M.
United Therapeutics made up 0.13% of Two Sigma Securities's portfolio in Q2 2026, its #172 holding.
Two Sigma Securities first reported a position in United Therapeutics in Q3 2015 and has held it in 16 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.